CHAPTER 3: Use of Molecular Modelling Techniques in Antibody-Drug Conjugate (ADC) Payload Discovery and Development

Paul J.M. Jackson*, David E. Thurston

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

3 Citations (Scopus)

Abstract

Computational drug discovery efforts have, historically, concentrated on molecular docking calculations, focusing on a "lock-and-key" theory, whereby a rigid ligand structure is fitted in its lowest energy minimum conformation into a rigid receptor followed by calculation of affinity. Potential hits are then ranked using a docking "score".

Original languageEnglish
Title of host publicationTherapies for Retinal Degeneration
Subtitle of host publicationTargeting Common Processes
EditorsDavid E. Thurston, Paul J. M. Jackson
PublisherRoyal Society of Chemistry
Pages57-72
Number of pages16
Edition71
DOIs
Publication statusPublished - 1 Jan 2019

Publication series

NameRSC Drug Discovery Series
Number71
Volume2019-January
ISSN (Print)2041-3203
ISSN (Electronic)2041-3211

Fingerprint

Dive into the research topics of 'CHAPTER 3: Use of Molecular Modelling Techniques in Antibody-Drug Conjugate (ADC) Payload Discovery and Development'. Together they form a unique fingerprint.

Cite this